When a client with congestive heart failure is prescribed captopril, what symptom should be reported to the healthcare provider?

Captopril is an angiotensin-converting enzyme (ACE) inhibitor commonly used in managing congestive heart failure. One of the notable side effects of captopril is its potential to cause hypotension, particularly after the first dose or with dosage increases. Dizziness is a common symptom associated with low blood pressure and can indicate the need for a dosage adjustment or close monitoring of the client’s blood pressure.

Although weight loss, muscle cramps, and dry mucous membranes could be concerns for a patient taking captopril, they are not as immediately significant as dizziness in the context of this medication. Weight loss may indicate various issues, including dietary changes or fluid loss, which can be managed with careful assessment. Muscle cramps might suggest electrolyte imbalances, which can also occur with certain medications but are less urgent compared to dizziness. Dry mucous membranes could be a sign of dehydration or other conditions but are not a direct side effect of captopril that necessitates immediate attention.

Therefore, the symptom that warrants prompt reporting to the healthcare provider is dizziness, as it may indicate an acute effect of the medication that could lead to falls or other complications in a patient with compromised heart function.